Skip to main content

Table 3 Cholangitis and mortality

From: Comparison of the efficacy and safety between palliative biliary stent placement and duct clearance among elderly patients with choledocholithiasis: a propensity score-matched analysis

Total number of patients

EBS

Complete stone removal

p value

nā€‰=ā€‰25

nā€‰=ā€‰25

Follow-up period, median (range), days

456 (8ā€“1676)

378 (28ā€“2364)

0.88

Cholangitis, n (%)

12 (48.0)

1 (4.0)

<ā€‰0.01

Causes of cholangitis

Ā Ā Ā 

Ā Stent migration, n (%)

7 (28.0)

Ā Ā 

Ā Stent occlusiona, n (%)

5 (20.0)

Ā Ā 

Ā Recurrence of choledocholithiasis, n (%)

Ā 

1 (4.0)

Ā 

Severity of cholangitis

Ā Ā Ā 

Ā Moderate, n (%)

11 (44.0)

1 (4.0)

Ā 

Ā Severe, n (%)

1 (4.0)

Ā Ā 

Mortality, n (%)

3 (12.0)

2 (8.0)

1.00

Causes of mortality

Ā Ā Ā 

Ā Pneumonia

1 (4.0)

Ā Ā 

Ā Renal failure

1 (4.0)

Ā Ā 

Ā Severe cholangitis

1 (4.0)

Ā Ā 

Ā Gastric cancer

Ā 

2 (8.0)

Ā 

Length of hospital stay, median (range), days

16 (2ā€“396)

11 (2ā€“35)

0.27

  1. aIncluding a patient with stentā€“stone complex formation